Catheter Precision, Inc. VTAK
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 219.17% | 130.35% | 95.00% | 82.96% | 37.61% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 219.17% | 130.35% | 95.00% | 82.96% | 37.61% |
| Cost of Revenue | 2,076.09% | 95.83% | 50.00% | 42.11% | 35.29% |
| Gross Profit | 64.98% | 134.18% | 100.00% | 87.26% | 37.81% |
| SG&A Expenses | -1.35% | -8.45% | 6.40% | 13.09% | 13.86% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.93% | -3.29% | 11.46% | 17.05% | 15.39% |
| Operating Income | 0.36% | 8.61% | -8.34% | -14.62% | -14.48% |
| Income Before Tax | 22.34% | -6.44% | -44.46% | -36.34% | -87.38% |
| Income Tax Expenses | -142.47% | -152.17% | -157.62% | -- | -- |
| Earnings from Continuing Operations | 31.49% | 14.84% | -6.32% | -49.56% | -102.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -47.56% | -- | -- | -- | -- |
| Net Income | 31.20% | 17.73% | -3.24% | -45.78% | -99.16% |
| EBIT | 0.36% | 8.61% | -8.34% | -14.62% | -14.48% |
| EBITDA | -1.89% | 8.70% | -10.69% | -18.37% | -18.10% |
| EPS Basic | 89.95% | 92.01% | 91.80% | 83.78% | 70.00% |
| Normalized Basic EPS | 97.67% | 96.41% | 94.20% | 91.23% | 76.97% |
| EPS Diluted | 89.95% | 92.01% | 91.80% | 83.78% | 70.00% |
| Normalized Diluted EPS | 97.67% | 96.41% | 94.20% | 91.23% | 76.97% |
| Average Basic Shares Outstanding | 319.01% | 376.07% | 528.02% | 1,291.07% | 1,153.89% |
| Average Diluted Shares Outstanding | 319.01% | 376.07% | 528.02% | 1,291.07% | 1,153.89% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |